US 8460675
Viral chemokine-antigen fusion proteins
granted A61KA61K2039/505A61K39/39541
Quick answer
US patent 8460675 (Viral chemokine-antigen fusion proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Jun 11 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K39/39541, A61P, A61P31/12